Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ORGO
#3351
Organogenesis Holdings Inc. - Class A
2.3
5
USD
+0.04%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.52%
Monthly Change
-1.67%
6 month change
-39.74%
Year Change
-45.22%
Previous Close
2.2
7
Open
2.3
1
Low
2.3
0
High
2.3
5
Volume
380
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
ORGO
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
127.99 M
128.77 M
131.18 M
131.96 M
126.83 M
128.64 M
128.67 M
Valuation ratios
Enterprise value
949.04 M
1.15 B
310.66 M
501.88 M
270.28 M
572.68 M
226.45 M
Price to earnings ratio
47.06
13.01
21.75
102
-320
34.53
-20.58
Price to sales ratio
2.48
2.64
0.77
1.25
0.87
1.2
0.62
Price to cash flow ratio
123.3
19.93
13.9
17.52
29.66
-65.45
10.63
Price to book ratio
5.74
5.1
1.3
1.94
1.6
2.25
0.31
Enterprise value to EBITDA ratio
27.21
13.47
9.34
17.69
21.9
11.07
-26.48
Profitability ratios
Return on assets %
0.06
0.21
0.03
0.01
0
0.06
-0.1
Return on equity %
0.12
0.39
0.06
0.02
0
0.12
-0.22
Return on invested capital %
78.49
70.11
24.78
8.17
0.53
33.28
-51.95
Gross margin %
74.19
75.6
76.71
75.42
75.99
98.54
110.63
Operating margin %
8.1
15.58
4.95
2.89
-0.27
7.92
-185.05
EBITDA margin %
10.31
18.24
7.37
6.55
2.56
9.17
-163.21
Net margin %
5.31
20.28
3.44
1.14
0.18
6.56
-142.79
Liquidity ratios
Quick ratio
2.15
2.46
2.64
2.44
3.35
3.32
3.16
Current ratio
2.56
2.77
2.97
2.8
3.69
3.62
3.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
1.31
1.27
1.01
0.95
1.01
1.03
0.07
Solvency ratios
Debt to assets ratio
0.24
0.17
0.16
0.15
—
—
—
Debt to equity ratio
0.48
0.3
0.27
0.24
—
—
—
Long term debt to total assets ratio
0.24
0.17
0.16
0.14
0
—
—
Long term debt to total equity ratio
0.48
0.31
0.27
0.24
0
—
—
Per share metrics
Operating cash flow per share
0.06
0.46
0.19
0.23
0.11
-0.08
0.23
EBIT per share
0.25
0.55
0.17
0.09
-0.01
0.28
-0.2
EBITDA per share
0.31
0.64
0.25
0.21
0.09
0.4
-0.08
Total debt per share
0.63
0.55
0.53
0.51
—
—
—
Cash per share
0.76
0.85
0.77
0.78
1.03
0.72
0.72
Net current asset value per share
1.57
1.7
1.68
1.7
2.17
2.78
2.1
Tangible book value per share
1.31
1.81
2.01
2.1
2
2.3
1.91
Working capital per share
0.95
1.08
1.11
1.09
1.58
2.01
1.51
Book value per share
1.31
1.81
2.01
2.1
2
2.3
1.91
News
Organogenesis: Mesmerized By Wound Care Struggles, Upcoming ReNu Blockbuster Overlooked
Organogenesis Holdings Inc. (ORGO) Q1 2026 Earnings Call Transcript
Organogenesis: Clinical Win De-Risks 2026, Recovery In Sight (NASDAQ:ORGO)
Why is Organogenesis Stock (ORGO) Up 20% Today? - TipRanks.com
Organogenesis Facing Hard Times As It Adjusts To CMS Rule Changes (NASDAQ:ORGO)
Organogenesis director Leibowitz buys $13k in ORGO stock
Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript
Organogenesis Holdings extends leases for Canton facilities through 2032
Coupang and Regencell among market cap stock movers on Friday
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision
Organogenesis stock rises after initiating FDA application for knee arthritis treatment
Organogenesis begins FDA rolling review for knee arthritis treatment